Data: JSON API · Download JSON · Download CSV
| Trade Name | Manufacturer | First Authorized | Disease |
|---|---|---|---|
| mRESVIA | Moderna | 2024 (United States) | (1) Respiratory syncytial virus (RSV) |
| mNEXSPIKE | Moderna | 2025 (United States) | (1) COVID-19 |
| mCombriax | Moderna Biotech Spain, S.L. | 2026 (European Union) | (2) COVID-19, Influenza |
| ZyVac TCV | Zydus Lifesciences | Unknown | (1) Typhoid |
| ZyCoV-D | Cadila Healthcare | 2021 (India) | (1) COVID-19 |
| Zostavax | Merck | 2006 (United States) | (1) Shingles / Zoster |
| Zifivax / ZF2001 | Anhui Zhifei Longcom / Institute of Microbiology at the Chinese Academy of S | Unknown | (1) COVID-19 |
| Zabdeno | Janssen / Johnson & Johnson | 2020 (European Union) | (1) Ebola |
| YF-Vax | Sanofi Pasteur | Unknown | (1) Yellow fever |
| Walrinvax | Yuxi Zerun Biotechnology | 2022 (China) | (1) Human papillomavirus infection (HPV) |
| WIBP-CorV | Sinopharm | 2021 (China) | (1) COVID-19 |
| Vivotif | Emergent BioSolutions / Crucell Switzerland AG | 1983 (Europe) | (1) Typhoid |
| Vimkunya | Bavarian Nordic | 2025 (United States) | (1) Chikungunya |
| Vidprevtyn | Sanofi Pasteur / GlaxoSmithKline | 2022 (European Union) | (1) COVID-19 |
| ViATIM | Sanofi Pasteur | Unknown | (2) Hepatitis A, Typhoid |
| Vaxigrip | Sanofi Pasteur | Unknown | (1) Influenza |
| Vaxelis | MSP Vaccine Company / Sanofi Pasteur | 2016 (European Union) | (6) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Polio, Tetanus |
| Vaxchora | Emergent BioSolutions | 2016 (United States) | (1) Cholera |
| Varivax | Merck Vaccines | 1995 (United States) | (1) Chickenpox / Varicella |
| Varilrix | GlaxoSmithKline | 1984 (Germany) | (1) Chickenpox / Varicella |
| Vaqta | Merck | 1996 (United States) | (1) Hepatitis A |
| VLA2001 / VLA2101 | Valneva | 2022 (Bahrain) | (1) COVID-19 |
| VAXNEUVANCE | Merck Sharp & Dohme Corp | 2021 (United States) | (1) Streptococcus pneumoniae |
| Typhim Vi | Sanofi Pasteur | 1988 (France) | (1) Typhoid |
| Typbar-TCV | Bharat Biotech International | 2012 (India) | (1) Typhoid |
| Twinrix | GlaxoSmithKline | Unknown | (2) Hepatitis A, Hepatitis B |
| Turkovac / ERUCOV-VAC | Health Institutes of Turkey / Erciyes University | 2021 (Türkiye) | (1) COVID-19 |
| Tresivac | Serum Institute of India | Unknown | (3) Measles, Mumps, Rubella |
| Tetraxim | Sanofi Pasteur | Unknown | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| TYPHIBEV | Biological E. | 2020 (India) | (1) Typhoid |
| TRUMENBA | Pfizer | 2014 (United States) | (1) Meningococcal disease |
| TICOVAC | Pfizer | 1976 (Austria) | (1) Tick-borne encephalitis |
| TENIVAC | Sanofi Pasteur | 2003 (United States) | (2) Diphtheria, Tetanus |
| TDVAX | MassBiologics | 1967 (United States) | (2) Diphtheria, Tetanus |
| Synflorix | GlaxoSmithKline | 2009 (European Union) | (1) Streptococcus pneumoniae |
| Supemtek | Sanofi Pasteur | Unknown | (1) Influenza |
| Stamaril | Sanofi Pasteur | Unknown | (1) Yellow fever |
| Sputnik V / Gam-COVID-Vac | Gamaleya Research Institute of Epidemiology and Microbiology | 2020 (Russia) | (1) COVID-19 |
| Spikevax | Moderna | 2020 (United States) | (1) COVID-19 |
| Soberana 02 / Pasteurcovac | Finlay Institute / Pasteur Institute of Iran | Unknown | (1) COVID-19 |
| Sinopharm CNBG COVID-19 vaccine | China National Biotec Group (CNBG) / Sinopharm | Unknown | (1) COVID-19 |
| Shingrix | GlaxoSmithKline | 2017 (United States) | (1) Shingles / Zoster |
| Shanvac B | Shantha Biotechnics / Sanofi | Unknown | (1) Hepatitis B |
| Shanchol | Sanofi Pasteur | Unknown | (1) Cholera |
| ShanTT | Sanofi Pasteur | Unknown | (1) Tetanus |
| ShanIPV | Sanofi Pasteur | Unknown | (1) Polio |
| Shan5 | Sanofi Pasteur | Unknown | (5) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Tetanus |
| SKYVaricella Inj. | SK Bioscience | Unknown | (1) Chickenpox / Varicella |
| SKYTyphoid Multi Inj. | SK Bioscience | Unknown | (1) Typhoid |
| Rotavac | Bharat Biotech | Unknown | (1) Rotavirus |
| Rotasiil | Serum Institute of India | Unknown | (1) Rotavirus |
| Rotarix | GlaxoSmithKline | 2004 (Mexico) | (1) Rotavirus |
| RotaTeq | Merck Sharp & Dohme Corp | 2006 (United States) | (1) Rotavirus |
| Revaxis | Sanofi Pasteur | 2003 (United Kingdom) | (3) Diphtheria, Polio, Tetanus |
| Recombivax HB | Merck | 1986 (United States) | (1) Hepatitis B |
| Razi Cov Pars | Razi Vaccine and Serum Research Institute | Unknown | (1) COVID-19 |
| Rabivax-S | Serum Institute of India | Unknown | (1) Rabies |
| Rabipur | Valneva | 1984 (Germany) | (1) Rabies |
| RabAvert | GlaxoSmithKline / Bavarian Nordic | 1997 (United States) | (1) Rabies |
| REPEVAX | Sanofi Pasteur | 2001 (United Kingdom) | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| R21/Matrix-M / CYVAC | Serum Institute of India / University of Oxford | 2023 (Ghana) | (1) Malaria |
| Quadracel | Sanofi Pasteur | 1997 (Canada) | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| Qdenga | Takeda | 2022 (Indonesia) | (1) Dengue fever |
| QazCovid-in / QazVac | Research Institute for Biological Safety Problems | 2020 (Kazakhstan) | (1) COVID-19 |
| QIV | Sanofi Pasteur | Unknown | (1) Influenza |
| ProQuad | Merck Vaccines | 2005 (United States) | (4) Chickenpox / Varicella, Measles, Mumps, Rubella |
| Priorix-Tetra | GlaxoSmithKline | 2007 (United Kingdom) | (4) Chickenpox / Varicella, Measles, Mumps, Rubella |
| Priorix | GlaxoSmithKline | 1997 (United Kingdom) | (3) Measles, Mumps, Rubella |
| Prevnar 20 | Pfizer | 2021 (United States) | (1) Streptococcus pneumoniae |
| Prevnar 13 | Pfizer | 2009 (European Union) | (1) Streptococcus pneumoniae |
| PreHevbrio | VBI Vaccines Inc. | Unknown | (1) Hepatitis B |
| Pneumovax 23 | Merck Sharp & Dohme Corp | 1983 (United States) | (1) Streptococcus pneumoniae |
| Pneumosil | Serum Institute of India | Unknown | (1) Streptococcus pneumoniae |
| Pentaxim | Sanofi Pasteur | Unknown | (5) Diphtheria, Haemophilus influenzae type b (Hib), Pertussis / Whooping cough, Polio, Tetanus |
| Pentacel | Sanofi Pasteur | 1997 (Canada) | (5) Diphtheria, Haemophilus influenzae type b (Hib), Pertussis / Whooping cough, Polio, Tetanus |
| Penmenvy | GlaxoSmithKline | 2025 (United States) | (1) Meningococcal disease |
| Penbraya | Pfizer | 2023 (United States) | (1) Meningococcal disease |
| PedvaxHIB | Merck Sharp & Dohme Corp. | 1989 (United States) | (1) Haemophilus influenzae type b (Hib) |
| Pediarix | GlaxoSmithKline | 2002 (United States) | (5) Diphtheria, Hepatitis B, Pertussis / Whooping cough, Polio, Tetanus |
| PNEUBEVAX 14 | Biological E. | Unknown | (1) Streptococcus pneumoniae |
| Nuvaxovid / Covovax | Novavax | 2021 (Indonesia) | (1) COVID-19 |
| Nimenrix | Pfizer | 2012 (European Union) | (1) Meningococcal disease |
| Mvabea | Janssen / Johnson & Johnson | 2020 (European Union) | (1) Ebola |
| Mosquirix | GlaxoSmithKline | Unknown | (1) Malaria |
| Menveo | GlaxoSmithKline | 2010 (United States) | (1) Meningococcal disease |
| Menjugate | GlaxoSmithKline | Unknown | (1) Meningococcal disease |
| Menitorix | GlaxoSmithKline | 2005 (United Kingdom) | (2) Haemophilus influenzae type b (Hib), Meningococcal disease |
| Menactra | Sanofi Pasteur | 2005 (United States) | (1) Meningococcal disease |
| MenQuadfi | Sanofi Pasteur | 2020 (United States) | (1) Meningococcal disease |
| MenFive | Serum Institute of India | Unknown | (1) Meningococcal disease |
| MenAfriVac | Serum Institute of India | Unknown | (1) Meningococcal disease |
| MVC-COV1901 | Medigen Vaccine Biologics / Dynavax Technologies / NIH | 2021 (Taiwan) | (1) COVID-19 |
| MVA-BN / Imvanex / Imvamune / Jynneos | Bavarian Nordic | 2013 (European Union) | (1) Smallpox |
| M-M-R II | Merck Vaccines | 1978 (United States) | (3) Measles, Mumps, Rubella |
| LC16 KMB / LC16m8 | KM Biologics | Unknown | (1) Smallpox |
| Kostaive | Seqirus Netherlands B.V. | 2023 (Japan) | (1) COVID-19 |
| Kinrix | GlaxoSmithKline | 2008 (United States) | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| KCONVAC | Beijing Minhai Biotechnology / Shenzhen Kangtai | 2021 (China) | (1) COVID-19 |
| Janssen / Johnson & Johnson COVID-19 vaccine | Janssen / Johnson & Johnson | 2021 (Bahrain) | (1) COVID-19 |
| JEEV | Biological E. | 2011 (India) | (1) Japanese encephalitis |
| Ixiaro | Valneva | 2009 (United States) | (1) Japanese encephalitis |
| Ixchiq | Valneva | 2023 (United States) | (1) Chikungunya |
| Infanrix IPV | GlaxoSmithKline | Unknown | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| Infanrix | GlaxoSmithKline | 1994 (Germany) | (3) Diphtheria, Pertussis / Whooping cough, Tetanus |
| Imovax Polio | Sanofi Pasteur | Unknown | (1) Polio |
| Imojev | Sanofi Pasteur | Unknown | (1) Japanese encephalitis |
| Imogam Rabies – HT | Sanofi Pasteur | Unknown | (1) Rabies |
| IPOL | Sanofi Pasteur | 1990 (United States) | (1) Polio |
| IMOVAX | Sanofi Pasteur | 1975 (Cameroon) | (1) Rabies |
| Hiberix | GlaxoSmithKline | Unknown | (1) Haemophilus influenzae type b (Hib) |
| Hexaxim | Sanofi Pasteur | 2013 (European Union) | (6) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Polio, Tetanus |
| Heplisav-B | Dynavax Technologies Corporation | 2017 (United States) | (1) Hepatitis B |
| Healive | Sinovac | Unknown | (1) Hepatitis A |
| Havrix | GlaxoSmithKline | Unknown | (1) Hepatitis A |
| HEXASIIL | Serum Institute of India | Unknown | (6) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Polio, Tetanus |
| HEV 239 | Xiamen Innovax Biotech | Unknown | (1) Hepatitis E |
| Genevac B | Serum Institute of India | Unknown | (1) Hepatitis B |
| Gardasil 9 | Merck | 2014 (United States) | (1) Human papillomavirus infection (HPV) |
| Gardasil | Merck Sharp & Dohme LLC | 2006 (United States) | (1) Human papillomavirus infection (HPV) |
| Fluzone Quadrivalent | Sanofi Pasteur | 2013 (United States) | (1) Influenza |
| Fluzone High Dose Quadrivalent | Sanofi Pasteur | 2019 (United States) | (1) Influenza |
| Flulaval QIV | GlaxoSmithKline | 2013 (United States) | (1) Influenza |
| Flucelvax Quadrivalent | Seqirus | 2016 (United States) | (1) Influenza |
| Flublok Quadrivalent | Sanofi Pasteur | 2016 (United States) | (1) Influenza |
| Fluarix QIV | GlaxoSmithKline | 2012 (United States) | (1) Influenza |
| Fluad Quadrivalent | Seqirus | 2020 (United States) | (1) Influenza |
| FluQuadri | Sanofi Pasteur | Unknown | (1) Influenza |
| Fendrix | GlaxoSmithKline | 2005 (European Union) | (2) Hepatitis A, Hepatitis B |
| FLU-M | Saint Petersburg Scientific Research Institute of Vaccines and Serums | Unknown | (1) Influenza |
| FAKHRAVAC | Organization of Defensive Innovation and Research | Unknown | (1) COVID-19 |
| Euvichol-S | EuBiologics | 2023 (Korea) | (1) Cholera |
| Euvichol-Plus | EuBiologics | Unknown | (1) Cholera |
| Eupolio Inj. | LG Chem | Unknown | (1) Polio |
| Eupenta | LG Chem | Unknown | (5) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Tetanus |
| Ervebo | Merck Sharp & Dohme Corp | 2019 (European Union) | (1) Ebola |
| EpiVacCorona | VECTOR Center of Virology | 2020 (Russia) | (1) COVID-19 |
| Epaxal | Crucell | Unknown | (1) Hepatitis A |
| Engerix-B | GlaxoSmithKline | Unknown | (1) Hepatitis B |
| Elovac B | Human Biologicals Institute–Indian Immunologicals Limited | Unknown | (1) Hepatitis B |
| Easyfive-TT | Panacea Biotec | Unknown | (5) Diphtheria, Haemophilus influenzae type b (Hib), Hepatitis B, Pertussis / Whooping cough, Tetanus |
| Dukoral | Valneva | 1991 (Sweden) | (1) Cholera |
| Dengvaxia | Sanofi Pasteur | 2015 (Mexico) | (1) Dengue fever |
| Daptacel | Sanofi Pasteur | 2002 (United States) | (3) Diphtheria, Pertussis / Whooping cough, Tetanus |
| Cyfendus | Emergent BioSolutions | 2023 (United States) | (1) Anthrax |
| Covishield / Vaxzevria | Oxford University–AstraZeneca | 2020 (United Kingdom) | (1) COVID-19 |
| Covidful | Chinese Academy of Medical Sciences | 2021 (China) | (1) COVID-19 |
| CoviVac | Chumakov Centre | 2021 (Russia) | (1) COVID-19 |
| Covaxin | Bharat Biotech | 2021 (India) | (1) COVID-19 |
| CoronaVac | Sinovac | 2020 (China) | (1) COVID-19 |
| Corbevax / BioE COVID-19 | Baylor College of Medicine | 2021 (India) | (1) COVID-19 |
| Convidecia | CanSino Biologics | 2020 (China) | (1) COVID-19 |
| Comirnaty | Pfizer–BioNTech | 2020 (United Kingdom) | (1) COVID-19 |
| Cervarix | GlaxoSmithKline | 2007 (Australia) | (1) Human papillomavirus infection (HPV) |
| Cecolin | Xiamen Innovax Biotech | 2019 (China) | (1) Human papillomavirus infection (HPV) |
| Capvaxive | Merck Sharp & Dohme | 2024 (United States) | (1) Streptococcus pneumoniae |
| COVIran Barekat | Shifa Pharmed Industrial / Barkat Pharmaceutical | 2021 (Iran) | (1) COVID-19 |
| COVAX-19 / SpikoGen | Vaxine | 2021 (Iran) | (1) COVID-19 |
| Boostrix IPV | GlaxoSmithKline | 2005 (United Kingdom) | (4) Diphtheria, Pertussis / Whooping cough, Polio, Tetanus |
| Boostrix | GlaxoSmithKline | 1999 (Germany) | (3) Diphtheria, Pertussis / Whooping cough, Tetanus |
| Biovac-A / Mevac-A | Pukang | Unknown | (1) Hepatitis A |
| BioThrax | Emergent BioDefense Corporation | 1998 (United States) | (1) Anthrax |
| Bimervax | HIPRA | 2023 (European Union) | (1) COVID-19 |
| Bexsero | GlaxoSmithKline | 2013 (European Union) | (1) Meningococcal disease |
| BIBP / BBIBP-CorV | Sinopharm | Unknown | (1) COVID-19 |
| BEVAC | Biological E. | Unknown | (1) Hepatitis B |
| BCG Vaccine | Organon Teknika | Unknown | (1) Tuberculosis |
| BARYCELA inj. | GC Biopharma | 2020 (Korea) | (1) Chickenpox / Varicella |
| Avaxim | Sanofi Pasteur | 1996 (France) | (1) Hepatitis A |
| Audenz | Seqirus, Inc. | 2020 (United States) | (1) Influenza |
| Arexvy | GlaxoSmithKline | 2023 (United States) | (1) Respiratory syncytial virus (RSV) |
| Arepanrix | GlaxoSmithKline Biologicals SA | 2009 (Canada) | (1) Influenza |
| Ambirix | GlaxoSmithKline | 2002 (European Union) | (2) Hepatitis A, Hepatitis B |
| Afluria Quadrivalent | Seqirus | 2016 (United States) | (1) Influenza |
| Adacel | Sanofi Pasteur | Unknown | (3) Diphtheria, Pertussis / Whooping cough, Tetanus |
| ActHIB | Sanofi Pasteur | 1992 (United Kingdom) | (1) Haemophilus influenzae type b (Hib) |
| Abrysvo | Pfizer | 2023 (United States) | (1) Respiratory syncytial virus (RSV) |
| Abdala | Center for Genetic Engineering and Biotechnology | Unknown | (1) COVID-19 |
| ACAM2000 | Sanofi Pasteur / Emergent BioSolutions | 2007 (United States) | (1) Smallpox |